Literature DB >> 6725551

Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly.

N Spirman, B A Sela, C Gitler, E Calef, M Schwartz.   

Abstract

An association between gangliosides and neuronal regeneration in goldfish is demonstrated in the present study. A single intraocular injection of affinity purified anti-GM1 antibodies administered simultaneously with crush injury of the optic nerve, inhibits the regenerating process as expressed by two parameters: protein synthesis in the retina and in vitro sprouting ability from the retina. The retinal level of several gangliosides (such as GD3, GD1a, GD1b and GT1b) is enhanced during regeneration. Although GM1 appears to be a minor retinal ganglioside, antibodies to GM1 exert a marked effect on retinal regenerative process. It is assumed that such antibodies could interact with more abundant retinal gangliosides such as GD1b which shows enhanced biosynthesis during regeneration and which shares a similar disaccharide terminal residue with GM1.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725551     DOI: 10.1016/0165-5728(84)90006-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Endogenous GM1 ganglioside of the plasma membrane promotes neuritogenesis by two mechanisms.

Authors:  Y Fang; G Wu; X Xie; Z H Lu; R W Ledeen
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

2.  Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier.

Authors:  F P Thomas; W Trojaborg; C Nagy; M Santoro; S A Sadiq; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Influence of exogenous gangliosides on the three-dimensional sprouting of goldfish retinal explants in vitro.

Authors:  U Sonnentag; H Rösner; H Rahmann
Journal:  Neurochem Res       Date:  1992-11       Impact factor: 3.996

Review 4.  Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.

Authors:  A E Warrington; M Rodriguez
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.